Patient Guide: Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 28 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04794101
Status: ACTIVE_NOT_RECRUITING
Condition: X-Linked Retinitis Pigmentosa
Phase: PHASE3

Where You Can Participate

This study is available at 28 locations across the country.

Top locations include:
  • • La Jolla, California
  • • Los Angeles, California
  • • Palo Alto, California
  • • And 25 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene - Join Clinical Trial NCTNCT04794101

How to Join This Clinical Trial - NCTNCT04794101

Learn how to participate in this PHASE3 trial studying an investigational therapy for X-Linked Retinitis Pigmentosa. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with X-Linked Retinitis Pigmentosa. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
X-Linked Retinitis Pigmentosa
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04794101 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 28 locations. Find a study site near you:

Clinical Research Site

La Jolla, California 92093 0946 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90027 - United States

Status: Contact for availability

Clinical Research Site

Palo Alto, California 94303 - United States

Status: Contact for availability

Clinical Research Site

Gainesville, Florida 32607 - United States

Status: Contact for availability

Clinical Research Site

Atlanta, Georgia 30322 - United States

Status: Contact for availability

Clinical Research Site

Boston, Massachusetts 02114 - United States

Status: Contact for availability

Clinical Research Site

Ann Arbor, Michigan 48105 - United States

Status: Contact for availability

Clinical Research Site

Durham, North Carolina 27705 - United States

Status: Contact for availability

Clinical Research Site

Pittsburgh, Pennsylvania 15213 - United States

Status: Contact for availability

Clinical Research Site

Bellaire, Texas 77401 - United States

Status: Contact for availability

And 18 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for X-Linked Retinitis Pigmentosa:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships